Authors


Ngofeen Mputubwele

Latest:

A Viral Colonial Legacy: HIV, Monkeypox Emerged Due to Ongoing Colonial Viral Neglect

Similar to HIV, the colonial and postcolonial history is fundamental to the biology of this monkeypox outbreak.


Mira Maximos, PharmD, MSc, ACPR

Latest:

The 5 Topics Every Infectious Disease Learner Should Read About, At Least Once!

In the latest Bench to Bedside column, clinicians provide information and resources on recommended topics learners should explore.


Deanna J. Buehrle, PharmD

Latest:

Bacterial Coinfections Among US Patients With Coronavirus Disease 2019

Implications for antimicrobial use and antimicrobial resistance.


Raneem H. Pallotta, PharmD

Latest:

NDM-Producing E coli Harboring PBP Insert Variants Emerges as New Threat

As with other metallo-β-lactamases, NDM is capable of hydrolyzing nearly all β-lactams, including carbapenems, and the search for the proper antimicrobials is challenging.


Kevin Nguyen, PharmD, BCIDP

Latest:

A Tale of 2 Settings: How Outpatient Clinics Differ From Institutions in Delivering Stewardship

Kevin Nguyen, PharmD, offers some insights on some of the challenges in the outpatient setting with regards to stewardship, and novel strategies being utilized.


Robbie Lee Anne Christian, Pharm.D., BCIDP, AAHIVP

Latest:

Examining RSV Vaccines for Seniors

Two RSV vaccines for seniors were FDA approved this year and here is an overview of the vaccines and the study data.



Catherine DeVoe, MD, and Peter Chin-Hong, MD

Latest:

Varicella Zoster Virus and Human Papillomavirus Vaccination in Immunocompromised Patients

Vaccination for VZV and HPV requires special consideration in immunocompromised patients. They are at risk for more severe viral illnesses if not immune, but they may also have decreased response to, and increased adverse effects from, vaccines.


Karen Tan, PharmD, BCIDP

Latest:

Optimizing Vancomycin Therapy: A Review of AUC Calculation Techniques

The ideal parameter for vancomycin monitoring is the area under the curve, which can be calculated using pharmacokinetic equations or Bayesian software.


Richelle L. Guerrero-Wooley, MD

Latest:

COVID-19 Impact on Antimicrobial Stewardship: Consequences and Silver Linings

This crisis has united multidisciplinary groups and laid the foundation to better equip the health care workforce for future pandemics.



Abdulwhab Shremo Msdi, PharmD

Latest:

Optimizing Vancomycin Therapy: A Review of AUC Calculation Techniques

The ideal parameter for vancomycin monitoring is the area under the curve, which can be calculated using pharmacokinetic equations or Bayesian software.


Rajeev Shah, PharmD, AAHIVP, BCIDP

Latest:

Ready, Set, Cabenuva: Implementing Cabotegravir/Rilpivirine

This novel therapeutic option represents the first long-acting injectable approved for maintenance of HIV-1 suppression.


Brandon Anderson, PharmD

Latest:

PEN-FAST Forward: Accelerating Penicillin Allergy De-Labeling

PEN-FAST is a validated risk stratification tool that promotes efficient, safe, and effective de-labeling of penicillin allergies.


Bo Ram Keum, PharmD candidate

Latest:

Safety of Cefazolin Has Been Underestimated for GBS Prophylaxis During Labor

Both undertreatment and overtreatment were common in this cohort of penicillin-allergic pregnant women with Group B Streptococcus (GBS).




Renata O. Smith, PharmD, AAHIVP

Latest:

Gender-Affirming Care in Persons Living With HIV

Gender-affirming hormone therapy (GAHT) therapy consists of administration of exogenous hormones and suppression of endogenous hormone production, with the goal of obtaining characteristics more congruent with an individual’s gender identity. Here is a review of these therapies and consideration for PrEP and the risks associated with HIV in this diverse population.


Kirby An, PharmD

Latest:

Trends in Carbapenemase-Producing Organisms: Prevalence, Treatment, and Outcomes

A study of carbapenemase-producing organisms found similar rates of infections, highlighting treatment challenges, the role of rapid diagnostics, and surveillance on antimicrobial stewardship due to high mortality rates.


Kari A. Mergenhagen, PHARMD, BCPS, BCIDP

Latest:

Outpatient Antimicrobial Stewardship: The Keys to Developing a Successful Program

This form of stewardship can reduce unnecessary antibiotic prescribing, reduce costs, and optimize patient outcomes.


Shane J. Softy

Latest:

Pharmacotherapy Options for COVID-19: Does Fluvoxamine Have a Place in Therapy?

The need for safe and effective treatment against the various strains of COVID-19 increase, and investigators continue to assess various pharmacologic options.


Aditya Shah, MBBS

Latest:

Infectious Diseases Provider Role in Extracorporeal Membrane Oxygenation Infections

There has been an emergence of extracorporeal membrane oxygenation-associated infections. Here is a review of how to define them and clinical management of this heterogeneous syndrome.


Tori Whitacre Martonicz

Latest:

Advancing Viral Disease Treatment of Recurrent Genital Herpes, Hepatitis B and D Viruses

The healthcare sector currently faces an unmet need in treating herpesviruses, hepatitis B, and hepatitis D, which could significantly improve patient outcomes. Addressing this involves considering the necessary steps and understanding the challenges pharmaceutical companies encounter as they work towards developing treatments for these conditions.


Jonathan H. Ryder, MD

Latest:

Updates and Controversies in Necrotizing Soft Tissue Infections

Changes in microbiology and antimicrobial resistance patterns warrant reevaluation of our current therapies for this condition.


Armand Butera

Latest:

CDC Influenza Surveillance Weekly Report

Clinical and public health laboratories reported increased influenza virus detections over the past few weeks, but US cases remains comparatively low to previous flu seasons.


Amy Carenza, BBA

Latest:

Infection Control: AP Technology's Impact on Reducing HAIs and AMR Pathogens

Deborah Birx, MD, and Amy Carenza, BBA, highlight the targeting of multidrug-resistant organisms and tracking of infection trends without increasing staffing needs.


Tiana Patriarca, PharmD candidate

Latest:

Linezolid Coadministration With Medications for Opioid Use Disorder: A Serotonin Toxicity Tightrope?

This study characterized the incidence of serotonin syndrome and identified contributing risk factors with combined medications for opioid use disorder (MOUD) and linezolid use.


Thein Myint, MBBS

Latest:

Sorry Ganciclovir, You’re Just Not the One for Me

Important clinical considerations to know about resistant CMV infections.


Laura L. Bio, PharmD, BCPS, BCIDP

Latest:

The Role of Pharmacists in the World of Pediatric Antimicrobial Stewardship

The limitation in the number of pediatric-specific guidelines by professional organizations, and results from large randomized clinical trials, may place an additional emphasis on literature evaluation skills for pediatric ASP pharmacists.


Jillian Walters, PharmD, MPH

Latest:

The ART of Implementing an Antiretroviral Stewardship Program

By addressing ART-related medication errors and increasing linkage to care, antiretroviral stewardship programs can improve management of inpatients with HIV.

© 2024 MJH Life Sciences

All rights reserved.